scFv-h3D6

N/A

Report date: 2025/03/20 16:05:08

Base Information

Drug NamescFv-h3D6

Drug Alias Nameanti-amyloid beta single-chain variable fragment (Universitat Autonoma de Barcelona)bapineuzumab derivative (Universitat Autonoma de Barcelona)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionBeta amyloid A4 protein inhibitors

TargetsBeta amyloid A4 protein

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySpain

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversitat Autonoma De Barcelona

China Registration ClassN/A

Develop Information

Active CompaniesUniversitat Autonoma De Barcelona

Inactive CompaniesN/A

Active IndicationsAlzheimer Disease

Inactive IndicationsN/A

Other Information

ATC CodeN/A